Rigel Pharmaceuticals, Inc. (RIGL)
30.68
+0.60
(+1.98%)
USD |
NASDAQ |
Jun 09, 16:00
30.68
0.00 (0.00%)
After-Hours: 19:03
Rigel Pharmaceuticals Total Assets (Quarterly) : 504.61M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 207.62B |
| Madrigal Pharmaceuticals, Inc. | 1.227B |
| CytomX Therapeutics, Inc. | 359.36M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 104.71M |
| Shareholders Equity (Quarterly) | 399.90M |
| Debt to Equity Ratio | 0.1143 |
| Current Ratio | 2.615 |
| Net Debt Paydown Yield | 0.57% |